Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $12 | $17 | $24 | $15 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $12 | $17 | $24 | $15 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -50.2% | 34.6% | 1.3% | – |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 63.4% | 41.4% | 61.9% | 59.5% |
| EBITDA | $0 | $1 | $0 | $0 |
| % Margin | 33.1% | 51.1% | 29% | 26.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 19.4% | 29.5% | 16.1% | 2.7% |
| EPS Diluted | 0.21 | 0.64 | 0.26 | 0.043 |
| % Growth | -67.2% | 146.2% | 510.3% | – |
| Operating Cash Flow | $0 | $1 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |